HomeQuestion

Do you offer neoadjuvant chemotherapy to nested variant urothelial carcinoma (NVUC) of the bladder?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Are there scenarios where you would still prefer adjuvant nivolumab based on known pathologic risk over using perioperative durvalumab for patients with muscle invasive bladder cancer?

How do you interpret NIAGARA efficacy given that adjuvant nivolumab was not administered in the comparator arm?

Would you consider utilizing pembrolizumab/enfortumab as a bladder preservation approach in patients with MIBC?

Do the results of IMvigor011 influence you to utilize ctDNA to guide all adjuvant IO in MIBC?

Which patients are you utilizing subcutaneous PD-1/L1 inhibitors instead of the intravenous formulation?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.